Literature DB >> 25029664

Criticizing reporting standards fails to improve quality in animal research.

Gordon P Otto, Ralf A Claus.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25029664      PMCID: PMC4056641          DOI: 10.1186/cc13804

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

We agree with Bara and Joffe that there is a need for improvement of reporting quality in animal research (AR) [1]. Presenting details on both methods used and potential cofounders during AR is not only important to reproduce results, and to ensure animal welfare (AW) and public support, it is a duty when animals are compromised, stressed or sacrificed to understand diseases or to identify treatment targets. The article addresses important issues, unfortunately without a solution and ignoring personal responsibility. As mentioned, the word count within manuscripts is strictly limited. In Germany and most European countries, the approval procedure for AR includes applications (>6,000 words) covering all analysed readouts: anaesthesia, pain control, euthanasia methods, termination criteria, statistical planning, funding, discussion of reduction, refinement and replacement, and a systematic review. Nevertheless, how should these long method descriptions be included in manuscripts of 3,500 words? Really what are required are special conferences and articles focusing on methods in AR, a uniform summarising data sheet as supplementary material, and the presentation of the registration number given by the AW committee including a recheck by the committees to ensure that AW was considered. Finally, there is a need for commitment among scientists to standardise experiments to allow collaborative exchange of data, body fluids and tissues to privilege synergetic benefits; to improve the informative value of an approach by stratification of animals [2]; and to also present negative results to avoid double testing. These changes will lead to increased quality in reporting, realisation of reduction, refinement and replacement, and public perception.

Authors’ response

Meredith Bara and Ari R Joffe

We agree with Otto and Claus that it is our moral duty to take sentient animals’ interests into consideration when performing AR that can cause suffering and early death. However, Otto and Claus believe we have not discussed ‘a solution’, and suggest that ‘a uniform summarising data sheet as supplementary material and the presentation of the registration number given by the AW committee’ would be steps forward. Although these would be welcome steps, they are not sufficient. We do not believe that the approval procedure for AR, including the longer submissions to the AW committee, can account for the poor ethical reporting we identified. For example: euthanasia methods in our review were often reported, yet not the appropriate method [1]; few systematic reviews of AR are published, most of low quality, and it is unlikely that the high-quality systematic reviews are presented to the AW committee yet never published [3]; reporting statistical planning and sample size calculations do not take significant space in manuscripts yet markedly improve internal validity, making nonreporting hard to explain; and there are problems with the AW committee approval process, including conflicts of interest, lack of strong public representation, and a culture of acceptance that AR is necessary in almost any circumstance [4,5]. Indeed, the poor reporting we identified may be a sign of poor performance of AW committees in general. Our ‘solution’ is thus for journals and reviewers to mandate adequate AR justification and reporting in manuscripts [1,6].

Abbreviations

AR: Animal research; AW: Animal welfare.

Competing interests

The authors declare that they have no competing interests.
  5 in total

Review 1.  Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis.

Authors:  François Lamontagne; Matthias Briel; Mark Duffett; Alison Fox-Robichaud; Deborah J Cook; Gordon Guyatt; Olivier Lesur; Maureen O Meade
Journal:  Crit Care Med       Date:  2010-12       Impact factor: 7.598

2.  Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.

Authors:  Marcin F Osuchowski; Judith Connett; Kathleen Welch; Jill Granger; Daniel G Remick
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

3.  Journal editorial policies, animal welfare, and the 3Rs.

Authors:  Nicola J Osborne; Daisy Payne; Michael L Newman
Journal:  Am J Bioeth       Date:  2009-12       Impact factor: 11.229

4.  Factors influencing the effectiveness of research ethics committees.

Authors:  C A Schuppli; D Fraser
Journal:  J Med Ethics       Date:  2007-05       Impact factor: 2.903

Review 5.  The ethical dimension in published animal research in critical care: the public face of science.

Authors:  Meredith Bara; Ari R Joffe
Journal:  Crit Care       Date:  2014-01-14       Impact factor: 9.097

  5 in total
  1 in total

1.  Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, and C3HeB/FeJ Mice (Mus musculus).

Authors:  Gordon P Otto; Birgit Rathkolb; Manuela A Oestereicher; Christoph J Lengger; Corinna Moerth; Kateryna Micklich; Helmut Fuchs; Valérie Gailus-Durner; Eckhard Wolf; Martin Hrabě de Angelis
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.